• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白受体缺陷兔经体外基因治疗后高胆固醇血症的长期改善

Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

作者信息

Chowdhury J R, Grossman M, Gupta S, Chowdhury N R, Baker J R, Wilson J M

机构信息

Department of Internal Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.

出版信息

Science. 1991 Dec 20;254(5039):1802-5. doi: 10.1126/science.1722351.

DOI:10.1126/science.1722351
PMID:1722351
Abstract

Familial hypercholesterolemia (FH) is an inherited disorder in humans that is caused by a deficiency of low density lipoprotein receptors (LDLRs). An animal model for FH, the Watanabe Heritable Hyperlipidemic rabbit, was used to develop an approach for liver-directed gene therapy based on transplantation of autologous hepatocytes that were genetically corrected ex vivo with recombinant retroviruses. Animals transplanted with LDLR-transduced autologous hepatocytes demonstrated a 30 to 50 percent decrease in total serum cholesterol that persisted for the duration of the experiment (122 days). Recombinant-derived LDLR RNA was harvested from tissues with no diminution for up to 6.5 months after transplantation.

摘要

家族性高胆固醇血症(FH)是一种人类遗传性疾病,由低密度脂蛋白受体(LDLR)缺乏引起。FH的动物模型——渡边遗传性高脂血症兔,被用于开发一种基于自体肝细胞移植的肝脏定向基因治疗方法,这些自体肝细胞在体外经重组逆转录病毒基因校正。移植了转导LDLR的自体肝细胞的动物,其血清总胆固醇降低了30%至50%,且在实验持续时间(122天)内一直保持。移植后长达6.5个月,从组织中收获的重组衍生LDLR RNA没有减少。

相似文献

1
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.低密度脂蛋白受体缺陷兔经体外基因治疗后高胆固醇血症的长期改善
Science. 1991 Dec 20;254(5039):1802-5. doi: 10.1126/science.1722351.
2
Ex vivo gene therapy of familial hypercholesterolemia.家族性高胆固醇血症的离体基因治疗。
Hum Gene Ther. 1992 Apr;3(2):179-222. doi: 10.1089/hum.1992.3.2-179.
3
In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses.
J Biol Chem. 1994 May 6;269(18):13695-702.
4
Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.移植转基因肝细胞的低密度脂蛋白受体缺陷兔高脂血症的短暂改善
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8437-41. doi: 10.1073/pnas.87.21.8437.
5
Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.纠正渡边遗传性高脂血症兔肝细胞中的基因缺陷。
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4421-5. doi: 10.1073/pnas.85.12.4421.
6
A novel approach to ex vivo gene therapy for familial hypercholesterolemia using human amniotic epithelial cells as a transgene carrier.
Tohoku J Exp Med. 2001 Apr;193(4):279-92. doi: 10.1620/tjem.193.279.
7
Transplantation of genetically modified hepatocytes after liver preconditioning in Watanabe heritable hyperlipidemic rabbit.在渡边遗传性高脂血症兔肝脏预处理后移植基因修饰的肝细胞。
J Surg Res. 2018 Apr;224:23-32. doi: 10.1016/j.jss.2017.11.060. Epub 2017 Dec 22.
8
Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits.体内肝细胞靶向基因转移可使低密度脂蛋白受体缺陷兔的高胆固醇血症得到短暂改善。
J Biol Chem. 1992 Jan 15;267(2):963-7.
9
Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.使用配体促进脂质体-LDL受体基因复合物转移的静脉内基因疗法治疗家族性高胆固醇血症。
Gene Ther. 2003 May;10(9):827-31. doi: 10.1038/sj.gt.3301953.
10
Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.
Mol Ther. 2004 Apr;9(4):548-56. doi: 10.1016/j.ymthe.2004.01.015.

引用本文的文献

1
Genetic Animal Models of Cardiovascular Pathologies.心血管疾病的遗传动物模型
Biomedicines. 2025 Jun 21;13(7):1518. doi: 10.3390/biomedicines13071518.
2
The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy.基因治疗的兑现承诺:肝脏定向基因治疗的过去、现在与未来
Mol Ther. 2025 May 7;33(5):1966-1987. doi: 10.1016/j.ymthe.2025.03.041. Epub 2025 Mar 27.
3
Gene transfer and genome editing for familial hypercholesterolemia.用于家族性高胆固醇血症的基因转移和基因组编辑
Front Mol Med. 2023 Apr 3;3:1140997. doi: 10.3389/fmmed.2023.1140997. eCollection 2023.
4
Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine.应对当代挑战:兽用纳米材料的发展
Pharmaceutics. 2023 Sep 15;15(9):2326. doi: 10.3390/pharmaceutics15092326.
5
Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.基于基因校正的单基因肝病新型治疗模式
Bioengineering (Basel). 2022 Aug 15;9(8):392. doi: 10.3390/bioengineering9080392.
6
The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis.载脂蛋白 E 基因缺陷兔模型的建立及其在动脉粥样硬化研究中的应用
J Atheroscler Thromb. 2020 Feb 1;27(2):119-131. doi: 10.5551/jat.RV17038-2. Epub 2019 Nov 21.
7
Molecular Dynamics Simulation Reveals Exposed Residues in the Ligand-Binding Domain of the Low-Density Lipoprotein Receptor that Interacts with Vesicular Stomatitis Virus-G Envelope.分子动力学模拟揭示了与水疱性口炎病毒-G 包膜相互作用的低密度脂蛋白受体配体结合域中的暴露残基。
Viruses. 2019 Nov 15;11(11):1063. doi: 10.3390/v11111063.
8
Bile-duct proliferation as an unexpected side-effect after AAV2-LDLR gene transfer to rabbit liver.胆管增生是 AAV2-LDLR 基因转移到兔肝后的意外副作用。
Sci Rep. 2019 May 6;9(1):6934. doi: 10.1038/s41598-019-43459-1.
9
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1.自体基因和细胞治疗为遗传性酪氨酸血症 1 型的大型猪模型提供了安全且长期的治愈疗法。
Cell Transplant. 2019 Jan;28(1):79-88. doi: 10.1177/0963689718814188. Epub 2018 Nov 26.
10
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine.慢病毒载体介导的离体肝细胞基因治疗用于猪的自体移植
J Vis Exp. 2018 Nov 4(141). doi: 10.3791/58399.